Amneal Pharmaceuticals (AMRX) Other financing activities (2017 - 2026)

Amneal Pharmaceuticals' Other financing activities history runs 7 years deep, the most recent figure standing at $2.0 million for Q1 2026.

• In Q1 2026, Other financing activities changed N/A year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $77.0 million (down 52.62% YoY), while the FY2023 annual figure was $162.4 million, up 9666.39% from the prior year.
• Other financing activities was $2.0 million for Q1 2026 at Amneal Pharmaceuticals, down from $73.2 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $161.9 million in Q4 2023 to a low of $41000.0 in Q3 2022.
• Historically, Other financing activities has averaged $39.9 million across 4 years, with a median of $1.9 million in 2025.
• Biggest YoY gain for Other financing activities was 1221.95% in 2023; the steepest drop was 1221.95% in 2023.
• A 4-year view of Other financing activities shows it stood at $41000.0 in 2022, then surged by 394712.2% to $161.9 million in 2023, then slumped by 54.76% to $73.2 million in 2025, then sank by 97.29% to $2.0 million in 2026.
• The last three Other financing activities figures came in at $2.0 million (Q1 2026), $73.2 million (Q3 2025), and $1.7 million (Q2 2025), per Business Quant data.